Creative Planning
PRAX icon

Creative Planning’s Praxis Precision Medicines PRAX Stock Holding History

Creative Planning’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.52M Sell
13,512
-2,774
-17% -$878K ﹤0.01% 1488
2026
Q1 		$5.25M Buy
16,286
+5,443
+50% +$1.68M ﹤0.01% 1152
2025
Q4 		$3.2M Buy
10,843
+4,183
+63% +$779K ﹤0.01% 1343
2025
Q3 		$353K Buy
6,660
+165
+3% +$8K ﹤0.01% 3021
2025
Q2 		$273K Buy
+6,495
New +$247K ﹤0.01% 2978
2025
Q1 		– Sell
-106
Closed -$8.16K – 3669
2024
Q4 		$8.16K Buy
+106
New +$7.67K ﹤0.01% 3391

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Creative Planning's PRAX Position: Q2 2026 in Review

Creative Planning reduced its Praxis Precision Medicines (PRAX) stake by 17% in Q2 2026, selling an estimated $878K and leaving 13,512 shares worth $4.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1488.

Creative Planning first reported a position in PRAX in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.25M in Q1 2026. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Creative Planning held 13,512 shares of Praxis Precision Medicines worth $4.52M as of Q2 2026.
  • Creative Planning sold 2,774 Praxis Precision Medicines shares in Q2 2026, an estimated $878K.
  • Praxis Precision Medicines made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1488 holding.
  • Creative Planning first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 6 quarters since.
  • Creative Planning's Praxis Precision Medicines position peaked at $5.25M in Q1 2026.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.